8-K: American Shared Hospital Services Secures $7 Million Loan, Appoints New CFO, and Gains Approval for Rhode Island Proton Therapy Center

American Shared Hospital Services secures a $7 million loan to finance acquisitions and capital expenditures, appoints a new CFO, and receives approval for a proton therapy center in Rhode Island.

Summary

• American Shared Hospital Services (ASHS) has entered into a second amendment to its credit agreement, securing a $7 million term loan.
• The loan proceeds will be used to finance the acquisition of a 60% membership interest in Southern New England Regional Cancer Center, LLC and Roger Williams Radiation Therapy, LLC, as well as other related transaction costs and capital expenditures.
• The new term loan matures on December 18, 2029, with interest-only payments for the first year, followed by equal monthly payments of principal and interest over seven years.
• ASHS's CFO, Robert Hiatt, resigned on December 19, 2024, and will remain with the company through January 31, 2025, to provide transition services.
• R. Scott Frech was appointed as the new CFO, effective immediately on December 19, 2024, with an annual base salary of $275,000 and a potential sign-on bonus of $30,000.
• Frech is also eligible for a performance bonus of 30% of his base salary in 2025 and received 50,000 restricted stock units (RSUs) that vest over five years.
• ASHS received a Certificate of Need to acquire the technology for a proton beam radiation treatment system in Johnston, Rhode Island, with the facility expected to be operational in 36-39 months.

Sentiment

Score: 7

Explanation: The document contains positive news regarding a new loan, a new CFO, and a certificate of need approval, but also includes the resignation of the previous CFO, which tempers the overall sentiment. The company is clearly growing and investing in the future.

Positives

• The $7 million loan provides necessary capital for strategic acquisitions and capital expenditures.
• The appointment of a new CFO with relevant experience in financial projections and operational strategies is a positive step.
• The Certificate of Need approval for the proton therapy center represents a significant growth opportunity for ASHS.
• The new proton therapy center will provide a much-needed service to the Rhode Island community, eliminating the need to travel out of state for treatment.

Negatives

• The resignation of the CFO, Robert Hiatt, creates a period of transition for the company's financial leadership.
• The company is taking on additional debt with the $7 million term loan.

Risks

• The new proton therapy center is not expected to be operational for 36-39 months, which could delay revenue generation.
• The company is taking on additional debt with the $7 million term loan, which could increase financial risk.
• The transition in CFO leadership could create some instability in the short term.

Future Outlook

The company anticipates the proton therapy facility will be built and treating its first patients in 36-39 months. The company also expects the new CFO to contribute to the company's growth and strategic initiatives.

Management Comments

• Ray Stachowiak, Executive Chairman and CEO, stated that the CON gives the opportunity to provide physicians with the most highly sophisticated radiation therapy technology.
• Greg Mercurio, Sr Vice President of Radiation Oncology, commented that bringing proton therapy to Rhode Island will be a significant investment and great technological advancement in cancer care.
• Ray Stachowiak noted that the company has recently added executives to its senior management team with expertise in the development, acquisition and operation of free standing radiation therapy facilities.

Industry Context

The announcement of the proton therapy center aligns with the trend of increasing access to advanced cancer treatment technologies. The location of the facility between New York City and Boston proton facilities will create greater access to this technology in the Northeast.

Comparison to Industry Standards

• The addition of a proton therapy center positions ASHS to compete with other major cancer treatment centers in the Northeast, such as those in Boston and New York City.
• The company's expansion into direct cancer care provision, rather than just technology supply, is a strategic shift that could lead to increased revenue and market share.
• The company's focus on acquiring and operating freestanding radiation therapy facilities is a common strategy in the healthcare industry to expand service offerings and reach more patients.

Management Changes

Stakeholder Impact

• Shareholders will benefit from the company's growth and strategic initiatives.
• Employees will experience changes in leadership and potential growth opportunities.
• Patients in Rhode Island will have increased access to advanced cancer treatment options.
• Creditors will be impacted by the new $7 million loan.

Next Steps

• The company will proceed with the construction of the proton therapy facility in Johnston, Rhode Island.
• The company will finalize the Variable Compensation Plan for the new CFO.
• The company will continue to integrate the acquired Rhode Island facilities into its operations.

Key Dates

Keywords

proton therapy, radiation therapy, capital expenditures, CFO, financial, acquisition, healthcare, loan, cancer treatment, certificate of need